Evolution Wealth Advisors, LLC Mirati Therapeutics, Inc. Transaction History

Evolution Wealth Advisors, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 28, 2022	SELL	$132.01 - $190.29 $3,168 - $4,566	-24 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$132.13 - $177.45 $6,077 - $8,162	-46 Reduced 65.71%	24 $4,000
Q2 2021 Jul 22, 2021	SELL	$144.0 - $179.73 $2,304 - $2,875	-16 Reduced 18.6%	70 $11,000
Q1 2021 Apr 20, 2021	SELL	$158.92 - $221.61 $953 - $1,329	-6 Reduced 6.52%	86 $15,000
Q4 2020 Feb 02, 2021	SELL	$162.05 - $240.27 $14,098 - $20,903	-87 Reduced 48.6%	92 $20,000
Q3 2020 Oct 15, 2020	SELL	$113.26 - $167.27 $11,779 - $17,396	-104 Reduced 36.75%	179 $30,000
Q1 2020 Apr 22, 2020	BUY	$69.78 - $116.21 $5,442 - $9,064	78 Added 38.05%	283 $22,000
Q4 2019 Feb 03, 2020	SELL	$70.76 - $128.86 $1,344 - $2,448	-19 Reduced 8.48%	205 $26,000
Q3 2019 Nov 12, 2019	BUY	$77.91 - $109.6 $1,791 - $2,520	23 Added 11.44%	224 $17,000
Q2 2019 Jul 12, 2019	BUY	$59.49 - $104.71 $11,957 - $21,046	201 New	201 $21,000

3.57M

36.6K

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

Get notified when there are updates to the investment portfolio of Evolution Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Evolution Wealth Advisors, LLC with notifications on news.